In the world of gallbladder adventures, a team unveils the secrets of common bile duct injury (CBDI) post-cholecystectomy in the U.S. Among 769,782 gallbladder enthusiasts, only 0.1% faced CBDI, linked to increased mortality risk. Biliary colic and obesity played guardian roles (lower risk), while pancreas disease and chronic liver disease spiked risks. Same-day CBDI repair […]
Category: General Surgery
Synthetic Mesh Holds Its Ground: Comparable Efficacy and Safety in Preventing Incisional Hernias Post Ileostomy Closure
In the Preloop trial, 97 patients underwent loop ileostomy closure with either retrorectus synthetic or biological mesh. Results at 10 months showed comparable outcomes—2% incisional hernia rates in both groups, and no significant differences in complications, reoperation rates, or hospital stay. The findings suggest synthetic mesh’s efficacy and safety match up to its biological counterpart, […]
HIPEC Consensus: Dutch Protocol Prevails for Colorectal Cancer Peritoneal Metastases
Global Experts Agree: In treating colorectal cancer with peritoneal metastases, cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) extends median overall survival beyond 40 months. The consensus among 78% of international panelists highlights the conditionally recommended use of HIPEC post-surgery. The Dutch protocol, featuring mitomycin-C, gains preference over the short, high-dose oxaliplatin regimen. Despite weak evidence, […]
Certified Colorectal Surgeons Transform the Game: Reduced Mortality and Leaks in Laparoscopic Resections
Certified colorectal surgeons shine in laparoscopic low anterior resections! A study with 41,741 patients in Japan found colorectal-specific certified surgeons significantly lowered 30-day mortality (0.2%) and anastomotic leak rates (9.3%) compared to noncertified peers, especially those with biliary certification. The bottom line? When it comes to these surgeries, having a colorectal-certified surgeon on the team […]
Post-Surgery Employment: Japanese Colorectal Cancer Patients Achieve 79% Return Rate in 12 Months
Japanese colorectal cancer patients (stages I-III) witnessed promising employment outcomes within 12 months post-surgery, with a 79% return-to-work rate. The study identified risks for delayed return, including advanced tumor stage, stoma presence, severe complications, shorter work tenure, and lower return-to-work inclination. Factors contributing to unemployment at 12 months included stoma, reluctance to return, nonregular employment, […]
Hernia Center Labels: No Clear Edge in Ventral Hernia Repair Outcomes
In the quest for superior hernia care, researchers explored designated hernia centers (DHCs). Analyzing over 14,000 ventral hernia repairs (VHRs) from 261 sites, they found no clear advantage to DHCs. Surprisingly, non-designated hernia centers (NDHCs) displayed fewer 30-day complications and lower one-year hernia recurrence rates. The message? Current hernia center labels might not guarantee better […]
Irreversible Nerve Damage: The Pre-op Pain Predictor for Chronic Post-op Pain in Inguinal Hernia Patients
Inguinal hernia patients with pre-op pain face potential irreversible nerve damage, signaling a road to chronic post-op pain (CPIP). Studying 40 patients who underwent hernia repair, researchers found intraneural fibrosis within the ilioinguinal nerve in all pre-op pain cases. The fibrosis degree correlated positively with pain duration. This unveils a crucial link between pre-op pain […]
Subtotal vs. Total Adrenalectomy in Bilateral Pheochromocytoma – Less Insufficiency, More Recurrence?
In the world of adrenal gland dilemmas, researchers delve into the showdown between total adrenalectomy and its hip sibling, subtotal adrenalectomy, for bilateral pheochromocytoma. Analyzing 10 studies with 1202 patients, they uncover that subtotal adrenalectomy, while saving from adrenal insufficiency, packs a punch with a higher recurrence rate (14.1% vs. 2.6%) and lower post-surgery steroid […]
Navigating Neoadjuvant Therapies for Esophageal Cancer
In the exploration of treatments for advanced esophageal squamous cell carcinoma (ESCC), researchers compared outcomes of neoadjuvant chemotherapy (NCT), neoadjuvant chemoradiotherapy (NCRT), and neoadjuvant immunochemotherapy (NICT). NCRT and NICT groups exhibited superior pathological responses, with higher pathologic complete response rates (29.9% and 23.6%, respectively) compared to NCT (8.1%). NCRT significantly reduced lymph node metastasis in […]
Intraperitoneal Paclitaxel Shows Promise: Effective and Tolerable Combo for Gastric Cancer with Peritoneal Metastasis
In a phase II study, researchers explored the efficacy of intraperitoneal paclitaxel combined with S-1 and cisplatin for gastric cancer with peritoneal metastasis. Among 53 patients, the treatment achieved a 73.6% 1-year overall survival rate, meeting the primary endpoint. The median survival time was 19.4 months, and the 1-year progression-free survival rate reached 49.6%. While […]